Yanli Wu

机构：Chinese Academy of Sciences, Shanghai Institute of Materia Medica · ORCID：0009-0005-4562-7397

发表论文 8 篇 · 总被引 337 次 · h-index 5

代表论文

• Design and Efficacy of a Monovalent Bispecific PD-1/CTLA4 Antibody That Enhances CTLA4 Blockade on PD-1+ Activated T Cells (2021 · Cancer Discovery · 被引 183)
• pH-dependent Binding Engineering Reveals an FcRn Affinity Threshold That Governs IgG Recycling (2014 · Journal of Biological Chemistry · 被引 104)
• Abstract 2776: MEDI5752: A novel bispecific antibody that preferentially targets CTLA-4 on PD-1 expressing T-cells (2018 · Cancer Research · 被引 16)
• Fab-Arm Exchange Combined with Selective Protein A Purification Results in a Platform for Rapid Preparation of Monovalent Bispecific Antibodies Directly from Culture Media (2019 · Pharmaceutics · 被引 13)
• Construction of Recombinant Pichia pastoris Carrying a Constitutive AvBD9 Gene and Analysis of Its Activity (2015 · Journal of Microbiology and Biotechnology · 被引 9)
• Structural insights into selective and dual antagonism of EP2 and EP4 prostaglandin receptors (2025 · The EMBO Journal · 被引 3)